US 9511015
Methods and formulations for treating sialic acid deficiencies
granted A61KA61K31/335A61K31/35
Quick answer
US patent 9511015 (Methods and formulations for treating sialic acid deficiencies) held by Ultragenyx Pharmaceutical Inc. expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ultragenyx Pharmaceutical Inc.
- Grant date
- Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/335, A61K31/35, A61K31/7012, A61K9/0002